Eden Research PLC (AIM:EDEN, OTCQB:EDNSF) chief executive Sean Smith joined Proactive's Stephen Gunnion with details of a trading update for the company's 2021 financial year.
Smith telling Proactive that sales of its Cedroz and Mevalone products increased but the company was impacted by adverse currency effects.
Eden's seed treatment and insecticides tie-up with Corteva, the world’s fourth-largest agri-business, made “good progress” last year, he added.